Eli Lilly Q4 Preview: Obesity drug momentum, Medicare tailwinds lift analysts' optimism

Lilly has also signaled that seven more Phase 3 trials for retatrutide are expected to conclude in 2026, making it a pivotal ...
Indianapolis Business Journal

Trump draws attention to Lilly’s massive building spree. Here’s what’s in the works.

Eli Lilly and Co. has announced $50 billion in U.S. expansion commitments since 2020, including numerous manufacturing plants ...
WISH-TV

Lilly signs deal to develop treatments for hearing loss using gene-editing

U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the ...

Should You Buy Eli Lilly Before Feb. 4?

Is there another beat-and-raise in the pharmaceutical giant's near future?
Fierce Pharma

Lilly rounds out quartet of new US plants with $3.5B injectable and device facility in Pa.

On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding ...
StockStory.org on MSN

Eli Lilly (LLY) reports Q4: Everything you need to know ahead of earnings

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Eli Lilly beat analysts’ revenue expectations by 9.7% last ...

FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?

The target action date for orforglipron is now April 10.
BioSpace

As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum

After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to ...